《过渡期生长激素缺乏症诊断及治疗专家共识》解读

2021-08-06 中国实用儿科杂志

随着儿科临床医师对过渡期生长激素缺乏症(TGHD)的认识以及国外相关诊疗指南的发表,中华医学会儿科学分会内分泌遗传代谢学组制定了《过渡期生长激素缺乏症诊断及治疗专家共识》。

中文标题:

《过渡期生长激素缺乏症诊断及治疗专家共识》解读

发布机构:

发布日期:

2021-08-06

简要介绍:

随着儿科临床医师对过渡期生长激素缺乏症(TGHD)的认识以及国外相关诊疗指南的发表,中华医学会儿科学分会内分泌遗传代谢学组制定了《过渡期生长激素缺乏症诊断及治疗专家共识》。该共识就过渡期患者继续治疗的重要性,何时及如何评估TGHD,rhGH治疗剂量、监测及安全性等方面为临床医师提供了参考。该文对共识的主要内容进行解读,并结合我国目前实际情况进一步探讨。 

相关资料下载:
[AttachmentFileName(sort=1, fileName=《过渡期生长激素缺乏症诊断及治疗专家共识》解读.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e69051c0023001d9, title=《过渡期生长激素缺乏症诊断及治疗专家共识》解读, enTitle=, guiderFrom=中国实用儿科杂志, authorId=0, author=, summary=随着儿科临床医师对过渡期生长激素缺乏症(TGHD)的认识以及国外相关诊疗指南的发表,中华医学会儿科学分会内分泌遗传代谢学组制定了《过渡期生长激素缺乏症诊断及治疗专家共识》。, cover=https://img.medsci.cn/20211223/1640267071231_5579292.png, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Aug 06 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">随着儿科临床医师对过渡期生长激素缺乏症(TGHD)的认识以及国外相关诊疗指南的发表,中华医学会儿科学分会内分泌遗传代谢学组制定了《过渡期生长激素缺乏症诊断及治疗专家共识》。该共识就过渡期患者继续治疗的重要性,何时及如何评估TGHD,rhGH治疗剂量、监测及安全性等方面为临床医师提供了参考。该文对共识的主要内容进行解读,并结合我国目前实际情况进一步探讨。&nbsp;</span></p>, tagList=[TagDto(tagId=12306, tagName=生长激素缺乏症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12306, guiderKeyword=生长激素缺乏症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1875, appHits=64, showAppHits=0, pcHits=393, showPcHits=1811, likes=1, shares=12, comments=4, approvalStatus=1, publishedTime=Thu Dec 23 21:41:58 CST 2021, publishedTimeString=2021-08-06, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=5, createdBy=null, createdName=FUNNYMAN, createdTime=Thu Dec 23 21:52:48 CST 2021, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 07:24:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=《过渡期生长激素缺乏症诊断及治疗专家共识》解读.pdf)])
《过渡期生长激素缺乏症诊断及治疗专家共识》解读.pdf
下载请点击:
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1201408, encodeId=2f69120140860, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69633, encryptionId=2c326963394, topicName=生长激素缺乏症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:30:51 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183430, encodeId=6651118343038, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:24:12 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084109, encodeId=702d108410991, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 25 07:01:21 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1201408, encodeId=2f69120140860, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69633, encryptionId=2c326963394, topicName=生长激素缺乏症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:30:51 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183430, encodeId=6651118343038, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:24:12 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084109, encodeId=702d108410991, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 25 07:01:21 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2022-01-12 D-House

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1201408, encodeId=2f69120140860, content=<a href='/topic/show?id=2c326963394' target=_blank style='color:#2F92EE;'>#生长激素缺乏症#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=69633, encryptionId=2c326963394, topicName=生长激素缺乏症)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=医者仁者, createdTime=Thu Mar 10 15:30:51 CST 2022, time=2022-03-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1183430, encodeId=6651118343038, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220625/6f4f075937de4c5d9fc7ab3a1bc6d8c2/13a8a29e67044698af1fb74276589093.jpg, createdBy=b5c55099112, createdName=D-House, createdTime=Wed Jan 12 08:24:12 CST 2022, time=2022-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1084109, encodeId=702d108410991, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=555f5538552, createdName=微探, createdTime=Sat Dec 25 07:01:21 CST 2021, time=2021-12-25, status=1, ipAttribution=)]
    2021-12-25 微探

    学习学习

    0

拓展阅读

过渡期生长激素缺乏症诊断及治疗专家共识

中华医学会儿科学分会内分泌遗传代谢学组 · 2020-06-30

2023 NICE 技术鉴定指导意见:生长激素治疗3岁及以上人群生长发育障碍【TA863】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-02-01

2023 NICE 医疗技术创新简报:用于诊断生长激素缺乏症的马西瑞林 [MIB320]

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2023-03-28